CN1303290A - sPLA2抑制剂酯 - Google Patents
sPLA2抑制剂酯 Download PDFInfo
- Publication number
- CN1303290A CN1303290A CN99805672A CN99805672A CN1303290A CN 1303290 A CN1303290 A CN 1303290A CN 99805672 A CN99805672 A CN 99805672A CN 99805672 A CN99805672 A CN 99805672A CN 1303290 A CN1303290 A CN 1303290A
- Authority
- CN
- China
- Prior art keywords
- methyl
- phenylmethyl
- indol
- oxy
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8387398P | 1998-05-01 | 1998-05-01 | |
| US60/083873 | 1998-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1303290A true CN1303290A (zh) | 2001-07-11 |
Family
ID=22181214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99805672A Pending CN1303290A (zh) | 1998-05-01 | 1999-04-20 | sPLA2抑制剂酯 |
Country Status (22)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6140327A (en) * | 1999-05-12 | 2000-10-31 | Eli Lilly And Company | Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor |
| WO2001044185A1 (en) * | 1999-12-16 | 2001-06-21 | Eli Lilly And Company | Carbon monoxide-based synthesis of spla2 inhibitors |
| DE19962300A1 (de) * | 1999-12-23 | 2001-06-28 | Asta Medica Ag | Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung |
| CN1450893A (zh) * | 2000-07-14 | 2003-10-22 | 伊莱利利公司 | 治疗脓毒症的方法 |
| EP2154958A4 (en) * | 2007-05-03 | 2011-05-04 | Anthera Pharmaceuticals Inc | TREATMENT OF HEART CIRCULATION DISEASES AND DYSLIPIDEMIA WITH INHIBITORS OF SECRETARY PHOSPHOLIPASE A2 (SPLA2) AND SPLA2 HEMMER COMBINATION THERAPIES |
| US8048880B2 (en) | 2007-05-03 | 2011-11-01 | Anthera Pharmaceuticals, Inc. | Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies |
| US20150335498A1 (en) * | 2014-05-22 | 2015-11-26 | The Procter & Gamble Company | Heterogenous mass containing foam |
| US10729600B2 (en) | 2015-06-30 | 2020-08-04 | The Procter & Gamble Company | Absorbent structure |
| PL3370664T3 (pl) | 2015-11-04 | 2022-03-07 | The Procter & Gamble Company | Wyrób chłonny zawierający strukturę chłonną |
| WO2017079599A1 (en) | 2015-11-04 | 2017-05-11 | The Procter & Gamble Company | Absorbent structure |
| WO2017079605A1 (en) | 2015-11-04 | 2017-05-11 | The Procter & Gamble Company | Method for determining bunch compression |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2036307C (en) * | 1990-03-08 | 2002-07-09 | Susan Jean Ward | 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method |
| EP1950200B1 (en) * | 1994-04-01 | 2012-01-11 | Eli Lilly And Company | [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| DE4435477A1 (de) * | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indol- und -azaindol-derivate |
| US6297269B1 (en) * | 1995-06-06 | 2001-10-02 | Pfizer Inc. | Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| CA2358492A1 (en) * | 1998-12-21 | 2000-06-29 | Eli Lilly And Company | Combination therapy for the treatment of sepsis |
-
1999
- 1999-04-20 ID IDW20002216A patent/ID27812A/id unknown
- 1999-04-20 JP JP2000546777A patent/JP4459441B2/ja not_active Expired - Fee Related
- 1999-04-20 KR KR1020007012114A patent/KR20010071197A/ko not_active Withdrawn
- 1999-04-20 CN CN99805672A patent/CN1303290A/zh active Pending
- 1999-04-20 HR HR20000738A patent/HRP20000738A2/hr not_active Application Discontinuation
- 1999-04-20 DE DE69921314T patent/DE69921314T2/de not_active Expired - Lifetime
- 1999-04-20 SK SK1633-2000A patent/SK16332000A3/sk unknown
- 1999-04-20 WO PCT/US1999/008538 patent/WO1999056752A1/en not_active Ceased
- 1999-04-20 BR BR9910149-1A patent/BR9910149A/pt not_active IP Right Cessation
- 1999-04-20 AU AU36525/99A patent/AU755901B2/en not_active Ceased
- 1999-04-20 PL PL99344571A patent/PL344571A1/xx not_active IP Right Cessation
- 1999-04-20 TR TR2000/03198T patent/TR200003198T2/xx unknown
- 1999-04-20 ES ES99918666T patent/ES2230847T3/es not_active Expired - Lifetime
- 1999-04-20 AT AT99918666T patent/ATE280155T1/de not_active IP Right Cessation
- 1999-04-20 CA CA002331036A patent/CA2331036A1/en not_active Abandoned
- 1999-04-20 EP EP99918666A patent/EP1073440B1/en not_active Expired - Lifetime
- 1999-04-20 NZ NZ507391A patent/NZ507391A/en unknown
- 1999-04-20 HU HU0201636A patent/HUP0201636A1/hu unknown
- 1999-04-20 IL IL13920399A patent/IL139203A0/xx unknown
- 1999-04-20 EA EA200001141A patent/EA003277B1/ru not_active IP Right Cessation
-
2000
- 2000-10-10 ZA ZA200005561A patent/ZA200005561B/en unknown
- 2000-10-31 NO NO20005477A patent/NO315940B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005477D0 (no) | 2000-10-31 |
| NO20005477L (no) | 2000-10-31 |
| WO1999056752A1 (en) | 1999-11-11 |
| JP4459441B2 (ja) | 2010-04-28 |
| ES2230847T3 (es) | 2005-05-01 |
| EP1073440A4 (en) | 2002-07-17 |
| AU755901B2 (en) | 2003-01-02 |
| DE69921314D1 (de) | 2004-11-25 |
| HUP0201636A1 (en) | 2002-09-28 |
| DE69921314T2 (de) | 2006-02-09 |
| IL139203A0 (en) | 2001-11-25 |
| PL344571A1 (en) | 2001-11-05 |
| JP2002513761A (ja) | 2002-05-14 |
| EP1073440A1 (en) | 2001-02-07 |
| BR9910149A (pt) | 2001-10-02 |
| AU3652599A (en) | 1999-11-23 |
| EA200001141A1 (ru) | 2001-04-23 |
| KR20010071197A (ko) | 2001-07-28 |
| NO315940B1 (no) | 2003-11-17 |
| SK16332000A3 (sk) | 2001-06-11 |
| ZA200005561B (en) | 2002-01-10 |
| ATE280155T1 (de) | 2004-11-15 |
| TR200003198T2 (tr) | 2001-03-21 |
| EA003277B1 (ru) | 2003-04-24 |
| ID27812A (id) | 2001-04-26 |
| NZ507391A (en) | 2003-12-19 |
| HRP20000738A2 (en) | 2001-10-31 |
| CA2331036A1 (en) | 1999-11-11 |
| EP1073440B1 (en) | 2004-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1067067C (zh) | 杂环速激肽受体拮抗物 | |
| CN1234705C (zh) | 新的羟基吲哚、其作为磷酸二酯酶4抑制剂的应用及其制备方法 | |
| CN1098262C (zh) | 光学活性的哌啶化合物的酸加成盐和其制备方法 | |
| CN1028103C (zh) | 哌啶基苯并咪唑类化合物的制备方法 | |
| HK1049164A1 (zh) | 吲衍生物和其在治療骨質疏鬆中的應用以及其它應用 | |
| CN1144522A (zh) | 用作降低血胆固醇药物的取代氮杂环丁酮化合物 | |
| HU220221B (hu) | 1H-Indol-3-ecetsav-hidrazid-származékok, a vegyületeket tartalmazó gyógyászati készítmények és eljárás előállításukra | |
| CN1157375C (zh) | 吲哚衍生物及其药物组合物 | |
| EP1073440B1 (en) | sPLA 2 INHIBITOR ESTERS | |
| CN1025786C (zh) | 氨基甲酰基衍生物的制备方法 | |
| KR20000069248A (ko) | sPLA2 억제제인 페닐 아세트아미드 | |
| CN1208333C (zh) | 主要用于治疗骨质疏松的吲哚衍生物 | |
| EP1202963B1 (en) | Spla2 inhibitors | |
| CN1051302C (zh) | 3-(吲哚-3-基)丙烯酸衍生物及其用作nmda拮抗剂 | |
| CN1022241C (zh) | 3-酰基-2-氧代吲哚-1-羧酰胺抗炎剂的前药化合物的制备 | |
| CN1699342A (zh) | 新的羟基吲哚、其作为磷酸二酯酶4抑制剂的应用及其制备方法 | |
| US6274578B1 (en) | sPLA2 inhibitor ester | |
| CN1178529A (zh) | 用作速激肽受体拮抗剂的杂环取代的哌嗪酮衍生物 | |
| WO2007148775A1 (ja) | 鎖状アミン化合物 | |
| CN1653061A (zh) | 喹诺酮羧酸衍生物的制备方法 | |
| MXPA00010465A (en) | sPLA2 | |
| CZ20004051A3 (cs) | Ester jako inhibitor sPLA2 | |
| HK1033462A (en) | Novel processes and intermediates | |
| HK1036974B (en) | Indole derivatives and medicinal compositions containing the same | |
| CN1863769A (zh) | 氨基吡咯烷衍生物的制备方法和中间体化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |